deltatrials
Unknown PHASE1/PHASE2 INTERVENTIONAL 1-arm NCT03159364

Antigen-specific Cytotoxic T Cells in the Treatment of Opportunistic Infections

Phase I/II Multicenter Trial of Antigen-specific Cytotoxic T Cells in the Treatment of Opportunistic Infections

Sponsor: Shenzhen Geno-Immune Medical Institute

Conditions Adenovirus Infection BKV Infection CMV Infection EBV Infection Fungus Infection Pathogen Infection Tuberculosis
Interventions pathogen-specific CTLs
Updated 9 times since 2017 Last updated: Sep 18, 2019 Started: Jul 15, 2017 Primary completion: Jul 31, 2020 Completion: Dec 31, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on Adenovirus Infection and BKV Infection, this trial is ongoing. The trial is conducted by Shenzhen Geno-Immune Medical Institute and has accumulated 9 data snapshots since 2017. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

~Jun 2017 – ~Sep 2017 · 3 months · monthly snapshotRecruiting~Sep 2017 – ~Jun 2018 · 9 months · monthly snapshotRecruiting~Jun 2018 – ~Aug 2018 · 2 months · monthly snapshotRecruiting~Aug 2018 – ~Oct 2019 · 14 months · monthly snapshotRecruiting~Oct 2019 – ~Jan 2021 · 15 months · monthly snapshotRecruiting~Jan 2021 – ~Mar 2022 · 14 months · monthly snapshotRecruiting~Mar 2022 – ~Jul 2024 · 28 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – present · 22 months · monthly snapshotUnknown

Change History

9 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown PHASE1/PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE1/PHASE2

    Status: Unknown Status → Unknown · Phase: PHASE1_PHASE2 → PHASE1/PHASE2

  3. Mar 2022 — Jul 2024 [monthly]

    Unknown Status PHASE1_PHASE2

    Status: Recruiting → Unknown Status

  4. Jan 2021 — Mar 2022 [monthly]

    Recruiting PHASE1_PHASE2

  5. Oct 2019 — Jan 2021 [monthly]

    Recruiting PHASE1_PHASE2

▶ Show 4 earlier versions

  1. Aug 2018 — Oct 2019 [monthly]

    Recruiting PHASE1_PHASE2

  2. Jun 2018 — Aug 2018 [monthly]

    Recruiting PHASE1_PHASE2

  3. Sep 2017 — Jun 2018 [monthly]

    Recruiting PHASE1_PHASE2

  4. Jun 2017 — Sep 2017 [monthly]

    Recruiting PHASE1_PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Shenzhen Geno-Immune Medical Institute
Data source: Shenzhen Geno-Immune Medical Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations